Replies to post #2318 on Dynavax Technologies Corp (DVAX)

[jondoeuk]

That's debatable and if you have listened to some of the cc's and read the SEC filings, it's clear Heplisav-B isn't paying any of the bills and won't be any time soon. I can't see the two PhIII trials happening next year either.